Showing results (1531-1540 of 1,641) with videos related to

Sort By:
Pageof 165
Circulation Research|September 19, 2015
GDF11 does not rescue aging-related pathological hypertrophyShavonn C Smith, Xiaoxiao Zhang, Xiaoying Zhang, et al.
Transplantation Proceedings|April 6, 2005
Potential of aspirin to inhibit thrombotic microangiopathy in alpha1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboonsF J M F Dor, K Kuwaki, Y-L Tseng, et al.
Brachytherapy|May 2, 2025
Twice daily template-based interstitial brachytherapy for gynecologic cancers: What is the optimal dose?Ria Mulherkar, David Grimm, Paniti Sukumvanich, et al.
JACC. Basic to Translational Science|March 25, 2025
Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Multiple Animal Models of Heart FailureRajika Roy, Sarah M Schumacher, Haley Christine Murphy, et al.
Plos One|February 2, 2013
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomographyLinbo Liu, Kengyeh K Chu, Grace H Houser, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 25, 2017
Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse modelAmir Toib, Chen Zhang, Giulia Borghetti, et al.
Circulation Research|February 3, 2007
Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological propertiesXiongwen Chen, Rachel M Wilson, Hajime Kubo, et al.
Science (New York, N.Y.)|January 28, 2016
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscleBenjamin R Nelson, Catherine A Makarewich, Douglas M Anderson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 20, 2021
Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotypeAlexander R H Hobby, Remus M Berretta, Deborah M Eaton, et al.
Brachytherapy|September 21, 2020
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experienceA Keller, J L Rodríguez-López, A K Patel, et al.
Pageof 165